Human MDSCs from renal cell carcinoma (RCC) patients has been described as a subpopulation of activated PMN cells expressing markers of mature activated granulocytes, including high levels of CD66b and CD11b and low levels of CD62L and CD16 (10, 69). This evidence concerns the gene CEACAM8 and renal cell carcinoma.